Understanding prognosis
Prognosis means the likely course of a disease. Statistics describe large groups of people diagnosed years ago. They cannot tell you what will happen to you, and your own care team is the best guide.
Last reviewed October 27, 2026 against the sources listed at the end of this page.
In short
- Outlook depends on the stage, the cell type, where the cancer started, overall health, and how it responds to treatment.
- The American Cancer Society links longer survival with the epithelioid subtype, being able to carry out daily tasks, younger age, and being female, among other factors.
- Published survival rates are based on people diagnosed years ago and do not reflect newer treatments.
- It is fine not to want the numbers. It is also fine to ask your doctor directly.
A gentle note before the numbers
Some people want every statistic, and some want none. Both are reasonable. If you would rather not read survival figures, you can skip the table below and go to treatment options or finding a specialist.
What affects outlook
The American Cancer Society names the stage as an important factor and lists other factors linked to longer survival:
- being able to carry out normal daily tasks
- being younger
- being female
- having the epithelioid subtype
- having normal levels of red blood cells, white blood cells, and platelets
Where the cancer started also matters. NCI's summary for health professionals notes, for example, that among carefully selected people with peritoneal mesothelioma treated with cytoreductive surgery and HIPEC at centers with expertise, reported median survival approaches 3 to 4 years. (A median is the middle value: half of people live longer and half do not.) How a cancer responds to treatment matters too, and that is something no table can show at the start.
Pleural mesothelioma survival rates
The American Cancer Society publishes 5-year relative survival rates for pleural mesothelioma from the National Cancer Institute's SEER database. SEER does not use stages I to IV. It groups cancers by how far they had spread at diagnosis:
- Localized: limited to the pleura.
- Regional: spread to nearby structures or lymph nodes.
- Distant: spread to distant parts of the body.
| How far it had spread at diagnosis (SEER stage) | 5-year relative survival rate |
|---|---|
| Localized | 23% |
| Regional | 15% |
| Distant | 11% |
| All stages combined | 15% |
Source: American Cancer Society, based on people diagnosed with pleural mesothelioma from 2015 to 2021.
What these numbers cannot tell you
The American Cancer Society points out several limits:
- They apply only to the stage at diagnosis, not later.
- They do not account for age, overall health, subtype, whether the tumor could be removed, or response to treatment.
- They are based on people diagnosed and treated at least five years earlier. People diagnosed now may do better, because treatments have improved.
- They do not cover peritoneal or pericardial mesothelioma. Ask your care team about those.
Questions you might ask your doctor
- Given my stage and subtype, what are the goals of treatment?
- What would you expect if I choose this treatment, or no treatment?
- Am I eligible for any clinical trials?
- Who can help with symptoms now, while we plan treatment?
Why timing comes up in legal claims
Prognosis is a medical matter. It comes up in legal conversations only because the deadlines for legal claims are fixed by law, and some claims change in form after a death. If you are thinking about a claim, the statute of limitations and wrongful death pages explain how timing works, without pressure to act before you are ready.
Get our printable guide to diagnosis, treatment, and legal options by email.
Get the guideCommon questions
What is a 5-year relative survival rate?
It compares people with a cancer to people in the general population. If the rate is 30%, people with that cancer are, on average, about 30% as likely as people without it to be alive five years after diagnosis. It is an average for a large group, not a prediction for one person.
Is there anything that improves the outlook?
Treatment at a center experienced with mesothelioma, an accurate diagnosis of the subtype, and access to newer treatments such as immunotherapy and clinical trials are all worth discussing with your care team. Overall fitness also matters, which is why symptom control and nutrition are part of good care.
This page is general health information, summarized from the sources below. It is not medical advice. Talk with your own doctor or care team about your situation.
Sources
- Survival rates for pleural mesothelioma (American Cancer Society, SEER data for 2015 to 2021)
- Stages of mesothelioma: factors linked to longer survival (American Cancer Society)
- About mesothelioma: cell types (American Cancer Society)
- Mesothelioma treatment, health professional version (National Cancer Institute PDQ)